A study for a 61 year old woman who takes Decadron - from FDA reports


Summary

11,210 females aged 61 (±5) who take the same drug are studied. This is a personalized study for a 61 year old female patient who has Myeloma - Multiple. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Sep, 12, 2017

11,210 females aged 61 (±5) who take Decadron are studied.


Number of reports submitted per year:

Decadron for a 61-year old woman.

Information of the patient in this study:

  • Age: 61
  • Gender: female
  • Conditions: Myeloma - Multiple
  • Drugs taken:
    • Decadron (dexamethasone)

eHealthMe real world results:

Most common side effects over time

< 1 month:
  • thrombocytopenia
  • fever
  • febrile neutropenia
  • diarrhea
  • nausea
  • breathing difficulty
  • pneumonia
  • agranulocytosis
  • dehydration
  • nausea and vomiting
1 - 6 months:
  • thrombocytopenia
  • diarrhea
  • pneumonia
  • agranulocytosis
  • nausea
  • breathing difficulty
  • weakness
  • fever
  • febrile neutropenia
  • disease progression
6 - 12 months:
  • thrombocytopenia
  • pneumonia
  • sepsis
  • weakness
  • aseptic necrosis
  • diarrhea
  • dehydration
  • anaemia
  • fainting
  • agranulocytosis
1 - 2 years:
  • acute lymphocytic leukemia (all)
  • pneumonia
  • haemoglobin decreased
  • stomatitis
  • pulmonary embolism
  • fever
  • deep venous thrombosis
  • drowsiness
  • colon cancer
  • haematocrit decreased
2 - 5 years:
  • bone disorder
  • upper gastrointestinal haemorrhage
  • myelodysplastic syndrome
  • rashes
  • malignant neoplasm progression
  • nausea and vomiting
  • thrombocytopenia
  • mouth haemorrhage
  • tooth disorder
  • osteonecrosis of jaw
5 - 10 years:
  • ovarian cancer recurrent
  • bone disorder
  • infection
  • respiratory disorder
  • pain
  • jaw disorder
  • aseptic necrosis bone
10+ years:
n/a
not specified:
  • nausea
  • breathing difficulty
  • weakness
  • thrombocytopenia
  • fatigue
  • fever
  • pain
  • diarrhea
  • pneumonia
  • anaemia

Top conditions involved for these people *:

  • Breast Cancer (961 people, 8.57%)
  • Preventive Health Care (898 people, 8.01%)
  • Pain (538 people, 4.80%)
  • Lung Cancer - Non-Small Cell (443 people, 3.95%)
  • Nausea (436 people, 3.89%)

Top co-used drugs for these people *:

  • Revlimid (1,622 people, 14.47%)
  • Zofran (1,175 people, 10.48%)
  • Velcade (1,122 people, 10.01%)
  • Zometa (1,112 people, 9.92%)
  • Carboplatin (869 people, 7.75%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

Related studies:

Can you answer these questions?

More questions for: Decadron, Myeloma - multiple

You may be interested in these reviews

More reviews for: Decadron, Myeloma - multiple